Humana Inc. $HUM Shares Sold by Exencial Wealth Advisors LLC

Exencial Wealth Advisors LLC trimmed its position in Humana Inc. (NYSE:HUM) by 4.1% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 6,710 shares of the insurance provider’s stock after selling 290 shares during the period. Exencial Wealth Advisors LLC’s holdings in Humana were worth $1,640,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the company. Cary Street Partners Investment Advisory LLC raised its position in shares of Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock valued at $31,000 after buying an additional 46 shares during the period. Applied Finance Capital Management LLC increased its stake in Humana by 1.7% during the first quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider’s stock worth $779,000 after acquiring an additional 48 shares during the last quarter. Blue Trust Inc. increased its stake in Humana by 3.6% during the second quarter. Blue Trust Inc. now owns 1,367 shares of the insurance provider’s stock worth $334,000 after acquiring an additional 48 shares during the last quarter. Achmea Investment Management B.V. raised its position in Humana by 0.5% in the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider’s stock valued at $2,746,000 after purchasing an additional 49 shares during the period. Finally, Beech Hill Advisors Inc. lifted its stake in shares of Humana by 6.1% in the 1st quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider’s stock valued at $229,000 after purchasing an additional 50 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on HUM. Truist Financial set a $300.00 price objective on Humana in a research report on Tuesday, October 14th. Wolfe Research increased their target price on shares of Humana from $283.00 to $313.00 and gave the stock an “outperform” rating in a research note on Monday, October 6th. Robert W. Baird dropped their price target on shares of Humana from $300.00 to $297.00 and set a “neutral” rating for the company in a research report on Friday, July 25th. Guggenheim restated a “buy” rating on shares of Humana in a report on Friday, October 3rd. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Humana in a research report on Wednesday, October 8th. Eight research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $297.58.

Humana Stock Up 1.2%

Shares of NYSE:HUM opened at $291.14 on Friday. The firm has a market capitalization of $35.01 billion, a PE ratio of 22.34, a price-to-earnings-growth ratio of 1.68 and a beta of 0.42. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $315.35. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The firm’s 50-day moving average is $281.57 and its two-hundred day moving average is $259.05.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The business had revenue of $32.39 billion during the quarter, compared to analysts’ expectations of $31.85 billion. During the same period in the previous year, the business posted $6.96 EPS. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. Analysts predict that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a $0.885 dividend. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.2%. Humana’s payout ratio is 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.